Bibliografía


1Maher ER, Kaelin WG. von Hippel-Lindau disease. Medicine 1997;76:381-91.
2Seizinger BR, Rouleau GA, Ozelius LJ, Lane AH, Farmer GE,et al. Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature 1988; 17: 268-9.
3Richards FM, Payne SJ, Zbar B, Affara NA, Ferguson-Smith MA, Maher ER. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Mol Genet 1995; 4: 2139-43.
4Melmon KL, Rosen SW. Lindau's disease: review of the literature and study of a large kindred. Am J Med 1964; 36: 595-617.
5Wilding A, Ingham SL, Lallo F, Clancy T, Huson SH, et al. Life expectancy in hereditary cancer predisposing diseases: an observational study. J Med Genet 2012; 49: 264-269.
6Latif F, Tory K, Gnarra J, Yao M, Duh FM,et al. Identification of the von Hippel-Lindau tumor suppressor gene. Science 1993; 260:1317-2.
7Kaelin WG Jr. Molecular basis of the VHL hereditary cancer syndrome. Nat Rev Cancer 2002; 2:673-82.
8Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM, et al. Von Hippel-Lindau disease. The Lancet 2003; 361:2059-67.